

Sunshine Biopharma advances its lead coronavirus drug candidate into IND-enabling studies after strong preclinical results in animal models.
You can purchase shares of Sunshine Biopharma (NASDAQ:SBFM) through any online brokerage.
Other companies in Sunshine Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Sunshine Biopharma has a consensus price target of $1400.00.
The stock price for Sunshine Biopharma (NASDAQ: SBFM) is $2.77 last updated November 6, 2026 at 6:49 PM EST.
There are no upcoming dividends for Sunshine Biopharma.
Sunshine Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Sunshine Biopharma.
Sunshine Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs...